<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>With the aim of comparing the clinical features of Burkitt's like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) in HIV-infected patients and in the general population, we retrospectively analyzed 35 patients with HIV-positive non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) and 535 patients with HIV-negative NHL, from 1985 to 1990 </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 33 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were diagnosed at our institute: 18 without and 15 with <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e>; 3.3% and 43% of <z:hpo ids='HP_0000001'>all</z:hpo> HIV-seronegative and HIV-seropositive NHL respectively </plain></SENT>
<SENT sid="2" pm="."><plain>No significant differences were found between these two series concerning clinical features, with the exception of peripheral <z:mp ids='MP_0000702'>adenopathy</z:mp> that was more common in the HIV infected patients (p = 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>In both groups <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> was characterized by advanced stage and high incidence of bone marrow and gastrointestinal involvement </plain></SENT>
<SENT sid="4" pm="."><plain>Response rate was lower in the HIV-positive patients, but the difference was not significant </plain></SENT>
<SENT sid="5" pm="."><plain>No relevant differences in the toxicity after chemotherapy were observed </plain></SENT>
<SENT sid="6" pm="."><plain>The median survival in the HIV-infected patients was lower (7 months) than in the other group (14 months), with borderline statistical significance (p = 0.06) </plain></SENT>
</text></document>